354 related articles for article (PubMed ID: 22269279)
1. Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial.
Pickkers P; Heemskerk S; Schouten J; Laterre PF; Vincent JL; Beishuizen A; Jorens PG; Spapen H; Bulitta M; Peters WH; van der Hoeven JG
Crit Care; 2012 Jan; 16(1):R14. PubMed ID: 22269279
[TBL] [Abstract][Full Text] [Related]
2. Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury: A Randomized Clinical Trial.
Pickkers P; Mehta RL; Murray PT; Joannidis M; Molitoris BA; Kellum JA; Bachler M; Hoste EAJ; Hoiting O; Krell K; Ostermann M; Rozendaal W; Valkonen M; Brealey D; Beishuizen A; Meziani F; Murugan R; de Geus H; Payen D; van den Berg E; Arend J;
JAMA; 2018 Nov; 320(19):1998-2009. PubMed ID: 30357272
[TBL] [Abstract][Full Text] [Related]
3. Alkaline phosphatase treatment improves renal function in severe sepsis or septic shock patients.
Heemskerk S; Masereeuw R; Moesker O; Bouw MP; van der Hoeven JG; Peters WH; Russel FG; Pickkers P;
Crit Care Med; 2009 Feb; 37(2):417-23, e1. PubMed ID: 19114895
[TBL] [Abstract][Full Text] [Related]
4. Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associated acute kidney injury.
Pickkers P; Angus DC; Arend J; Bellomo R; van den Berg E; Bernholz J; Bestle M; Broglio K; Carlsen J; Doig CJ; Ferrer R; Joannidis M; Francois B; Doi K; Kellum JA; Laterre PF; Liu K; Mehta RL; Murray PT; Ostermann M; Pettilä V; Richards S; Young P; Zarbock A; Kjølbye AL
BMJ Open; 2023 Apr; 13(4):e065613. PubMed ID: 37012016
[TBL] [Abstract][Full Text] [Related]
5. Thiamine as a Renal Protective Agent in Septic Shock. A Secondary Analysis of a Randomized, Double-Blind, Placebo-controlled Trial.
Moskowitz A; Andersen LW; Cocchi MN; Karlsson M; Patel PV; Donnino MW
Ann Am Thorac Soc; 2017 May; 14(5):737-741. PubMed ID: 28207287
[TBL] [Abstract][Full Text] [Related]
6. Effect of alkaline phosphatase on sepsis-associated acute kidney injury patients: A systematic review and meta-analysis.
Tang W; Huang J; Huang X; Han X; Tang W; Ke G; Xu Q
Medicine (Baltimore); 2020 Jan; 99(4):e18788. PubMed ID: 31977869
[TBL] [Abstract][Full Text] [Related]
7. Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI).
Peters E; Mehta RL; Murray PT; Hummel J; Joannidis M; Kellum JA; Arend J; Pickkers P
BMJ Open; 2016 Sep; 6(9):e012371. PubMed ID: 27678541
[TBL] [Abstract][Full Text] [Related]
8. Acetate Ringer's solution versus 0.9% saline for septic patients: study protocol for a multi-center parallel controlled trial.
Liu F; Zhang J; Zhu Y; Su L; Li Y; He L; Yu L; Peng Z
Trials; 2021 Jan; 22(1):89. PubMed ID: 33494795
[TBL] [Abstract][Full Text] [Related]
9. Innovative Drugs to Target Renal Inflammation in Sepsis: Alkaline Phosphatase.
Hümmeke-Oppers F; Hemelaar P; Pickkers P
Front Pharmacol; 2019; 10():919. PubMed ID: 31507417
[TBL] [Abstract][Full Text] [Related]
10. Alkaline phosphatase as a treatment of sepsis-associated acute kidney injury.
Peters E; van Elsas A; Heemskerk S; Jonk L; van der Hoeven J; Arend J; Masereeuw R; Pickkers P
J Pharmacol Exp Ther; 2013 Jan; 344(1):2-7. PubMed ID: 23131595
[TBL] [Abstract][Full Text] [Related]
11. Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock.
Angstwurm MW; Engelmann L; Zimmermann T; Lehmann C; Spes CH; Abel P; Strauss R; Meier-Hellmann A; Insel R; Radke J; Schüttler J; Gärtner R
Crit Care Med; 2007 Jan; 35(1):118-26. PubMed ID: 17095947
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial cadherin shedding is more severe in sepsis patients with severe acute kidney injury.
Yu WK; McNeil JB; Wickersham NE; Shaver CM; Bastarache JA; Ware LB
Crit Care; 2019 Jan; 23(1):18. PubMed ID: 30658667
[TBL] [Abstract][Full Text] [Related]
13. C-terminal agrin fragment (CAF) reflects renal function in patients suffering from severe sepsis or septic shock.
Drey M; Behnes M; Kob R; Lepiorz D; Hettwer S; Bollheimer C; Sieber CC; Bertsch T; Hoffmann U
Clin Lab; 2015; 61(1-2):69-76. PubMed ID: 25807640
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of Yiqi Peiyuan granules for improving the short-term prognosis of patients with acute kidney injury: A multicenter, double-blind, placebo-controlled, randomized trial.
Wu JJ; Zhang TY; Qi YH; Zhu MY; Fang Y; Qi CJ; Cao LO; Lu JF; Lu BH; Tang LM; Shen JX; Mou S
J Integr Med; 2024 May; 22(3):279-285. PubMed ID: 38688809
[TBL] [Abstract][Full Text] [Related]
15. Alkaline phosphatase: a possible treatment for sepsis-associated acute kidney injury in critically ill patients.
Peters E; Heemskerk S; Masereeuw R; Pickkers P
Am J Kidney Dis; 2014 Jun; 63(6):1038-48. PubMed ID: 24462020
[TBL] [Abstract][Full Text] [Related]
16. Change in alkaline phosphatase activity associated with intensive care unit and hospital length of stay in patients with septic acute kidney injury on continuous renal replacement therapy.
Baek SD; Kang JY; Yu H; Shin S; Park HS; Kim MS; Lee EK; Kim SM; Chang JW
BMC Nephrol; 2018 Sep; 19(1):243. PubMed ID: 30236070
[TBL] [Abstract][Full Text] [Related]
17. The potential of alkaline phosphatase as a treatment for sepsis-associated acute kidney injury.
Peters E; Masereeuw R; Pickkers P
Nephron Clin Pract; 2014; 127(1-4):144-8. PubMed ID: 25343839
[TBL] [Abstract][Full Text] [Related]
18. Effects of levosimendan on renal blood flow and glomerular filtration in patients with acute kidney injury after cardiac surgery: a double blind, randomized placebo-controlled study.
Tholén M; Ricksten SE; Lannemyr L
Crit Care; 2021 Jun; 25(1):207. PubMed ID: 34118980
[TBL] [Abstract][Full Text] [Related]
19. The timing of continuous renal replacement therapy initiation in sepsis-associated acute kidney injury in the intensive care unit: the CRTSAKI Study (Continuous RRT Timing in Sepsis-associated AKI in ICU): study protocol for a multicentre, randomised controlled trial.
Chen WY; Cai LH; Zhang ZH; Tao LL; Wen YC; Li ZB; Li L; Ling Y; Li JW; Xing R; Liu XY; Lin ZD; Deng ZT; Wang SH; Lin QH; Zhou DR; He ZJ; Xiong XM
BMJ Open; 2021 Feb; 11(2):e040718. PubMed ID: 33608398
[TBL] [Abstract][Full Text] [Related]
20. Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL).
Pickkers P; Angus DC; Bass K; Bellomo R; van den Berg E; Bernholz J; Bestle MH; Doi K; Doig CJ; Ferrer R; Francois B; Gammelager H; Pedersen UG; Hoste E; Iversen S; Joannidis M; Kellum JA; Liu K; Meersch M; Mehta R; Millington S; Murray PT; Nichol A; Ostermann M; Pettilä V; Solling C; Winkel M; Young PJ; Zarbock A;
Intensive Care Med; 2024 Jan; 50(1):68-78. PubMed ID: 38172296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
